The Demise of the Absorb BVS: Lessons Learned From the Discontinuation of a Disappearing Stent

Brian G DeRubertis; Steven Kum; Ramon L Varcoe

doi:10.1177/1526602818799735

The Demise of the Absorb BVS: Lessons Learned From the Discontinuation of a Disappearing Stent

J Endovasc Ther. 2018 Dec;25(6):706-709. doi: 10.1177/1526602818799735. Epub 2018 Sep 12.

Authors

Brian G DeRubertis¹, Steven Kum², Ramon L Varcoe^{3

4

5}

Affiliations

¹ 1 Division of Vascular and Endovascular Surgery, University of California Los Angeles, CA, USA.
² 2 Vascular Service, Department of Surgery, Changi General Hospital, Singapore.
³ 3 Department of Surgery, Prince of Wales Hospital, Sydney, New South Wales, Australia.
⁴ 4 Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
⁵ 5 The Vascular Institute, Prince of Wales, Sydney, New South Wales, Australia.

PMID: 30205733
DOI: 10.1177/1526602818799735

No abstract available

Keywords: absorbable implants; angioplasty; critical limb ischemia; drug-eluting technology; infrapopliteal artery; ischemia; lower extremity; occlusion; peripheral artery disease; polymers; stenosis; tibial artery.

Publication types

Editorial
Comment

MeSH terms

Absorbable Implants*
Arteries
Everolimus
Stents*
Treatment Outcome

Substances

Everolimus